ICE is quietly shifting migrant supervision from detention beds to GPS ankle monitors and app check-ins — and the contractor running that program is booking software-like margins on a fraction of the capital.
The mechanism: Detention beds cost money to build, staff, and defend in court. A GPS ankle monitor and a check-in app cost a fraction of that per participant, scale up or down with a policy memo instead of a construction schedule, and generate a much softer political image than a detention wing on the evening news. That trade — capital-heavy incarceration for opex-light supervision — is ICE's Intensive Supervision Appearance Program (ISAP), run under contract by BI Incorporated, a wholly owned subsidiary of The GEO Group. BI just secured a new ISAP contract (effective October 1, 2025, structured as a two-year term with an option period) covering GPS monitoring, the SmartLINK check-in app, and case management for a population GEO itself has said runs in the hundreds of thousands. Inside that population, the mix has flipped hard toward hardware-plus-software: GPS ankle-bracelet enrollment has nearly tripled since early 2025 while phone-app-only monitoring has declined — a shift toward the higher-touch, higher-revenue-per-head tier of the same contract. This is a margin story wrapped in an enforcement story.
Who cashes in:
Every migrant ICE moves from a detention bed onto a GPS ankle monitor is a unit of higher-margin revenue for the same contractor — just booked in a different segment.
- GEO ($GEO) — Electronic Monitoring & Supervision Services is already a standalone, disclosed segment (roughly 12% of 2025 revenue) and is the only part of GEO's book that grows by shipping ankle bracelets and phone kits rather than pouring concrete. Every participant ICE moves from a detention bed — or from app-only check-ins — onto a GPS monitor is a unit of higher-margin, lower-capex revenue for BI Incorporated, and Wall Street increasingly prices GEO on this mix shift, not bed count.
- Axon ($AXON) — Not an ISAP contractor today, but the read-through is sector-wide: as "alternatives to detention" becomes the politically durable enforcement posture, the total addressable market for wearables, body-worn sensors, and connected case-management tech across DHS/ICE/state corrections expands, and Axon is the category's dominant hardware-plus-SaaS vendor with the balance sheet to bid into adjacent government monitoring work.
- Palantir ($PLTR) — ICE's back-end case-management and targeting data infrastructure (Palantir has long-standing ICE/HSI contracts) benefits directly when supervision scales to hundreds of thousands of check-ins, location pings, and compliance records that need to be fused, flagged, and actioned — the software layer sitting on top of exactly the kind of monitoring data ISAP generates.
Who is exposed:
- CoreCivic ($CXW) — CoreCivic's business is still overwhelmingly bricks-and-mortar detention beds; it has nowhere near GEO's footprint in electronic monitoring. If ICE's funding mix tilts toward cheaper per-capita monitoring instead of new detention capacity, CXW is structurally the loser in that reallocation, even as total ICE enforcement spending rises.
The play: Don't watch GEO's bed-occupancy numbers — watch the ISAP participant count and its ankle-monitor-versus-app split in each quarterly print. A rising monitored population with a rising GPS share is GEO re-rating from a prison REIT-adjacent story to a recurring-revenue govtech story, arguably deserving a different multiple. Watch DHS appropriations riders and any GEO 10-Q language on ISAP contract value versus detention segment revenue for the tell.
Source: original report ↗
Free alerts Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/mo Join the owners who run ahead of the industry. Cancel anytime, one click.